Cezary Kucharski
Edmonton, AB T6G2H1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Suppressing t(4;11) Acute Leukemia by Lipopolymer Nanoparticle Delivery of siRNA Targeting KMT2A::AFF1 with Enhanced Extrahepatic Delivery.
Journal: Advanced healthcare materials
Published: April 23, 2025
Cationic lipopolymer based siRNA delivery for experimental lung cancer treatment.
Journal: Biomaterials advances
Published: April 19, 2025
Lipopolymer/siRNA complexes engineered for optimal molecular and functional response with chemotherapy in FLT3-mutated acute myeloid leukemia.
Journal: Acta biomaterialia
Published: June 27, 2024
Lipopolymer/siRNA Nanoparticles Targeting the Signal Transducer and Activator of Transcription 5A Disrupts Proliferation of Acute Lymphoblastic Leukemia.
Journal: ACS pharmacology & translational science
Published: June 03, 2024
Tuning the Potency of Farnesol-Modified Polyethylenimine with Polyanionic Trans-Booster to Enhance DNA Delivery.
Journal: ACS biomaterials science & engineering
Published: February 09, 2024
Lipopolymer mediated siRNA delivery targeting aberrant oncogenes for effective therapy of myeloid leukemia in preclinical animal models.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: November 20, 2023
Transfection Efficacy and Cellular Uptake of Lipid-Modified Polyethyleneimine Derivatives for Anionic Nanoparticles as Gene Delivery Vectors.
Journal: ACS applied bio materials
Published: February 28, 2023
Improved delivery of Mcl-1 and survivin siRNA combination in breast cancer cells with additive siRNA complexes.
Journal: Investigational new drugs
Published: May 27, 2022
Polymeric siRNA delivery targeting integrin-β1 could reduce interactions of leukemic cells with bone marrow microenvironment.
Journal: Biomaterials and biosystems
Published: May 28, 2021
Therapeutic delivery of siRNA with polymeric carriers to down-regulate STAT5A expression in high-risk B-cell acute lymphoblastic leukemia (B-ALL).
Journal: PloS one
Published: September 15, 2020
Last Updated: 09/26/2026